PPARγ inhibition boosts efficacy of PD-L1 Checkpoint Blockade Immunotherapy against Murine Melanoma in a sexually dimorphic manner

Immune checkpoint blockade-based immunotherapy has become standard of care for multiple cancer types. However, the overall response rates among various cancer types still remain unsatisfactory. There is a pressing clinical need to identify combination therapies to improve efficacy of anticancer immu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Biol Sci
Main Authors: Wu, Bogang, Sun, Xiujie, Yuan, Bin, Ge, Fei, Gupta, Harshita B., Chiang, Huai-Chin, Li, Jingwei, Hu, Yanfen, Curiel, Tyler J., Li, Rong
Format: Artigo
Jezik:Inglês
Izdano: Ivyspring International Publisher 2020
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7097912/
https://ncbi.nlm.nih.gov/pubmed/32226299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijbs.42966
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki